MDAA yields 0.46% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, MDAA + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MDAA + PFE for your $10,000?
MDAA aims to outperform a 60/40 global equity-bond benchmark through a dynamic allocation across global equities, fixed income, and currencies. Investments consist of large- and mid-cap stocks, bond futures, currency derivatives, and low-cost index ETFs. The fund may also hold ADRs, GDRs, IDRs, and foreign securities. The equity portfolio ranges from nearly 100% exposure during bullish markets to zero or net short positions in bearish conditions. The fixed income allocations shift according to interest rate trends, and cash holdings increase during downturns to reduce risk. Currency exposure is managed through futures and options, with gold sometimes used as a proxy. The strategy is based on a top-down macroeconomic approach that shifts assets in response to economic, sector, and earnings outlooks. The fund may also use leverage through futures to amplify tactical returns.
Full MDAA Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.